Drugs for Asherman's Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 37)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dydrogesterone |
Approved, Investigational, Withdrawn |
Phase 4 |
|
152-62-5 |
9051 |
Synonyms:
(9Β,10Α)-PREGNA-4,6-DIENE-3,20-DIONE
10a-Isopregnenone
10alpha-Isopregnenone
10Α-isopregnenone
6 Dehydro 9 beta 10 alpha progesterone
6-Dehydro-9 beta-10 alpha-progesterone
6-Dehydro-retro-progesterone
9Β,10Α-PREGNA-4,6-DIENE-3,20-DIONE
Dehydrogesterone
delta(6)-Retroprogesterone
DELTA(SUP 6)-RETROPROGESTERONE
Didrogesterona
Didrogesterone
Duphaston
Duphaston®
|
DUPHASTON-HRT
DYDROGESTERONA
DYDROGESTERONE
DYDROGESTÉRONE
Dydrogesteronum
GESTATRON
Gynorest
Hydrogesterone
Hydrogestrone
Isopregnenone
NSC-92336
Retro-6-dehydroprogesterone
Solvay brand OF dydrogesterone
Δ(6)-retroprogesterone
|
|
2 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 4 |
|
9004-61-9 |
53477741 |
Synonyms:
(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate
(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
(2S,3S,4R,5R,6R)-3-{[(2S,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,6-trihydroxyoxane-2-carboxylate
2-Acetamido-2-deoxy-b-D-gluco-hexopyranosyl-(1->4)-b-D-gluco-hexopyranuronate
2-Acetamido-2-deoxy-b-D-gluco-hexopyranosyl-(1->4)-b-D-gluco-hexopyranuronic acid
2-Acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronate
|
2-Acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronic acid
2-Acetamido-2-deoxy-β-D-gluco-hexopyranosyl-(1->4)-β-D-gluco-hexopyranuronate
2-Acetamido-2-deoxy-β-D-gluco-hexopyranosyl-(1->4)-β-D-gluco-hexopyranuronic acid
Hyaluronan
Hyaluronate
WURCS=2.0/2,2,1/[a2122a-1b_1-5][a2122h-1b_1-5_2*ncc/3=o]/1-2/a4-b1
|
|
3 |
|
Dimenhydrinate |
Approved |
Phase 4 |
|
523-87-5 |
10660 |
Synonyms:
(O-BENZHYDRYL(DIMETHYLAMINO)ETHANOL) 8-CHLOROTHEOPHYLLINATE
1)
8-CHLORO-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE - 2-(DIPHENYLMETHOXY)-N,N-DIMETHYLETHANAMINE (1
8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)
ANTEMIN
BENZHYDRYL-BETA-DIMETHYLAMINOETHYLETHER 8-CHLOROTHEOPHYLLINE
Benzhydryl-β-dimethylaminoethylether 8-chlorotheophylline
BETA-DIMETHYLAMINOETHYL BENZHYDRYL ETHER 1,3-DIMETHYL-8-CHLOROXANTHINE
CHLORANAUTINE
DIMENHIDRINATO
DIMENHYDRINATE
|
DIMENHYDRINATUM
DIPHENHYDRAMINE 8-CHLOROTHEOPHYLLINATE
DIPHENHYDRAMINE 8-CHLOROTHEOPHYLLINE
DIPHENHYDRAMINE THEOCLATE
DIPHENHYDRINATE
DRAMAMINE
N,N-DIMETHYL-2-DIPHENYLMETHOXYETHYLAMINE 8-CHLOROTHEOPHYLLINATE
NSC-117855
O-BENZHYDRYLDIMETHYLAMINOETHANOL 8-CHLOROTHEOPHYLLINATE
VERTIGO-VOMEX S
β-dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine
|
|
4 |
|
Estrogens |
|
Phase 4 |
|
|
|
5 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
6 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
7 |
|
Progestins |
|
Phase 4 |
|
|
|
8 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
9 |
|
Viscosupplements |
|
Phase 4 |
|
|
|
10 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
11 |
|
Protective Agents |
|
Phase 4 |
|
|
|
12 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
13 |
|
Carboxymethylcellulose Sodium |
|
Phase 4 |
|
|
|
14 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 2 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Β)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Β oestradiol
17Β-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Β-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Β-estradiol
|
|
15 |
|
Polyestradiol phosphate |
Approved |
Phase 2 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
16 |
|
Estrone |
Approved |
Phase 2 |
|
53-16-7 |
5870 |
Synonyms:
(+)-ESTRONE
(1S,10R,11S,15S)-5-HYDROXY-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIEN-14-ONE
(8R,9S,13S,14S)-3-HYDROXY-13-METHYL-7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE
1,3,5(10)-ESTRATRIEN-3-OL-17-ONE
3-HYDROXY-1,3,5(10)-ESTRATRIEN-17-ONE
3-HYDROXY-17-KETO-ESTRA-1,3,5-TRIENE
3-HYDROXYESTRA-1,3,5(10)-TRIEN-17-ONE
3-HYDROXYESTRA-1,3,5(10)-TRIENE-17-ONE
3-HYDROXYOESTRA-1,3,5(10)-TRIEN-17-ONE
AQUEST
Aquest®|Kestrone®|oestrone
D1,3,5(10)-ESTRATRIEN-3-OL-17-ONE
E1
ESTROGENIC SUBSTANCE
ESTRONA
ESTRONE
Estrone, (+-)-isomer
|
Estrone, (8 alpha)-isomer
Estrone, (9 beta)-isomer
ESTRONE:E1
ESTRONUM
Estrovarin
FOLLICULAR HORMONE
FOLLICULIN
Hauck brand OF estrone
Hyrex brand OF estrone
KESTRONE
NSC-9699
OESTRONE
THEELIN
Unigen
Vortech brand OF estrone
WAY 164397
Wehgen
|
|
17 |
|
Estradiol 3-benzoate |
|
Phase 2 |
|
|
|
18 |
|
Estradiol 17 beta-cypionate |
|
Phase 2 |
|
|
|
19 |
|
Estropipate |
|
Phase 2 |
|
7280-37-7 |
|
Synonyms:
ESTROPIPATE
HARMOGEN
OGEN
OGEN .625
OGEN 1.25
|
OGEN 2.5
OGEN 5
ORTHO-EST
PIPERAZINE ESTRONE SULFATE
|
|
20 |
|
Anticoagulants |
|
Phase 2 |
|
|
|
21 |
|
Anti-Bacterial Agents |
|
Phase 1 |
|
|
|
22 |
|
Anesthetics |
|
Phase 1 |
|
|
|
23 |
|
Antibiotics, Antitubercular |
|
Phase 1 |
|
|
|
24 |
|
Carbamide peroxide |
Approved |
|
|
124-43-6 |
|
Synonyms:
Carbamide peroxide
Hydrogen peroxide carbamide
Urea dioxide
|
Urea hydrogen peroxide
Urea peroxide
|
|
25 |
|
Ethanol |
Approved |
Early Phase 1 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
26 |
|
Progesterone |
Approved, Vet_approved |
|
|
57-83-0 |
5994 |
Synonyms:
(1S,2R,10S,11S,14S,15S)-14-ACETYL-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
(8S,9S,10R,13S,14S,17S)-17-ACETYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9S,10R,13S,14S,17S)-17-ETHANOYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(S)-4-PREGNENE-3,20-DIONE
(S)-PREGN-4-EN-3,20-DIONE
(S)-PROGESTERONE
17ALPHA-PROGESTERONE
17A-PROGESTERONE
17Α-PROGESTERONE
3,20-PREGNENE-4
4-PREGNEN-3,20-DIONE
4-PREGNENE-3,20-DIONE
AGOLUTIN
AKROLUTIN
Amen
BETA-PROGESTERONE
BIO-LUTON
CIDR
COLPROSTERONE
CORLUTIN
CORLUTINA
CORLUVITE
CORPORIN
CORPUS LUTEUM HORMONE
CRINONE
CRINONE PROGESTERONE GEL
CURRETAB
CYCLOGEST
CYCLOGESTERIN
Cycrin
D4-PREGNENE-3,20-DIONE
DELALUTIN
DELTA(4)-PREGNENE-3,20-DIONE
DELTA(SUP 4)-PREGNENE-3,20-DIONE
DURAPROGEN
ENDOMETRIN
ESTIMA
FLAVOLUTAN
FOLOGENON
Gelbkoerperhormon
GELBKÖRPERHORMON
GESTEROL
GESTEROL 100
GESTEROL 50
GESTIRON
GESTONE
GESTORMONE
GESTRON
GLANDUCORPIN
GYNLUTIN
GYNOLUTON
GYNOLUTONE
HORMOFLAVEINE
HORMOLUTON
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
LINGUSORBS
LIPO-LUTIN
LUCORTEUM
LUCORTEUM SOL
LUGESTERON
LUTEAL HORMONE
Luteinique
LUTEOCRIN NORMALE
LUTEODYN
LUTEOGAN
LUTEOHORMONE
LUTEOL
LUTEOPUR
LUTEOSAN
LUTEOSTAB
LUTEOVIS
LUTEUM
LUTEX
LUTIDON
LUTIGEST
|
Lutin
LUTOCICLINA
LUTOCUCLIN M
LUTOCYCLIN
LUTOCYCLIN M
LUTOCYLIN
LUTOCYLOL
LUTOFORM
LUTOGYL
LUTOGYNON
LUTREN
LUTROMONE
MEMBRETTES
METHYLPREGNONE
MPA
NALUTRON
NSC-64377
NSC-9704
PERCUTACRINE
PERCUTACRINE LUTEINIQUE
PIAPONON
PRANONE
PREGN-4-EN-3,20-DIONE
PREGN-4-ENE-3,20-DIONE
PREGNENE-3,20-DIONE
PREGNENEDIONE
PRIMOLUT
PROCHIEVE
PROGEFFIK
PROGEKAN
PROGESTA-CARE
PROGESTAN
PROGESTASERT
PROGESTEROL
PROGESTERON
PROGESTERONA
Progesterona [INN-Spanish]
PROGESTERONE
PROGESTÉRONE
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
PROGESTERONUM
Progesteronum [INN-Latin]
PROGESTIN
PROGESTOGEL
PROGESTOL
PROGESTON
PROGESTONE
PROGESTOSOL
PROGESTRON
PROGESTRONOL
PROJESTAJECT
PROLETS
PROLIDON
PROLUTIN
PROLUTON
PROLUTONE
PROMETRIUM
Prometrium®|Utrogestan®
PRONTOGEST
PROTORMONE
REGUMATE
SERENITY FOR WOMEN
SYNGESTERONE
SYNGESTRETS
SYNGESTRONE
SYNOVEX S
SYNTOLUTAN
Thiuram E
Thiuranide
U 3672
UTROGEST
UTROGESTAN
VITARRINE
Δ(4)-pregnene-3,20-dione
|
|
27 |
|
Heparin, bovine |
Approved, Investigational, Withdrawn |
|
|
9005-49-6 |
22833565 9812414 772 |
Synonyms:
Adomiparin
alpha-Heparin
Ariven
Arteven
Bemiparin
BOVINE HEPARIN
Calcilean
CALCIPARINE
Certoparin
CLEXANE
Clexane®|enoxaparin sodium|Lovenox®|PK-10169|RP-54563
Clivarin
Clivarine
DALTEPARIININATRIUM
Dalteparin
DALTEPARIN SODIUM
dalteparin sodium|Fragmin®
DALTEPARIN SODNÁ SŮL
DALTEPARIN SODYUM
DALTEPARINA SODICA
DALTEPARINA SÓDICA
DALTEPARINE SODIQUE
DALTÉPARINE SODIQUE
DALTEPARINNATRIUM
DALTEPARIN-NATRIUM
DALTEPARIN-NÁTRIUM
DALTEPARINO NATRIO DRUSKA
DALTEPARINUM NATRICUM
DALTEPARYNA SODOWA
Depo-Heparin
ENOXAPARIN
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM (PRESERVATIVE FREE)
ENOXAPARIN SODIUM SALT
Eparina
Eparina [DCIT]
Fluxum
FR-860
FRAGMIN
Fragmin A
Fragmin B
Fraxiparin
Hed-Heparin
Hepalean
HEPARIN
Heparin Cy 216
|
HEPARIN FRAGMENT KABI 2165
Heparin Leo
Heparin Lock Flush
HEPARIN SODIUM
Heparin sodium preservative Free
Heparin sodium salt
Heparin sulfate
Heparin sulphate
Heparina
HEPARINATE
Heparine
HEPARINIC ACID
Heparinsodiumsalt
Heparinum
Hepathrom
HepFlush®
HEP-LOCK
KABI-2165
Leparan
Lipo-Hepin
LIQUAEMIN
Liquaemin Sodium
Liquemin
LOVENOX
LOVENOX (PRESERVATIVE FREE)
LOW LIQUEMINE
Low molecular weight heparin sodium
Multiparin
Novoheparin
Pabyrin
PANHEPRIN
Parnaparin
Parnaparin sodium
Parvoparin
PK-10169
Pularin
Reviparin
RP-54563
Sandoparin
SODIUM HEPARIN
Sublingula
TEDELPARIN
Thromboliquine
Unfractionated heparin
Vetren
Vitrum AB
|
|
28 |
|
Plerixafor |
Approved |
Early Phase 1 |
|
110078-46-1 |
65015 |
Synonyms:
1,1'-(1,4-Phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane)octahydrochloride dihydrate
1,1'-(1,4-Phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate
AMD 3100
AMD 3100|AMD3100|bicyclam JM-2987|JM 3100|Mozobil®
AMD3100
AMD-3100
Bicyclam
BICYCLAM JM-2987
|
JM 3100
Mezobil
Mozobil
PLERIXAFOR
Plerixafor hydrochloride
Plerixafor octahydrochloride
RPA bicyclam
|
|
29 |
|
Fibrinolytic Agents |
|
|
|
|
|
30 |
|
Calcium heparin |
|
|
|
|
|
31 |
|
Hormones |
|
Early Phase 1 |
|
|
|
32 |
|
Antiviral Agents |
|
Early Phase 1 |
|
|
|
33 |
|
Anti-Retroviral Agents |
|
Early Phase 1 |
|
|
|
34 |
|
Anti-Infective Agents |
|
Early Phase 1 |
|
|
|
35 |
|
Anti-HIV Agents |
|
Early Phase 1 |
|
|
|
36 |
|
Chorionic Gonadotropin |
|
Early Phase 1 |
|
|
|
37 |
|
Ethylene |
|
|
|
74-85-1 |
6325 |
Synonyms:
Acetene
Aethen
Aethylen
Athylen
Bicarburretted hydrogen
CH2=ch2
Elayl
Ethene
Ethene (9ci)
Ethene, 9ci
Ethylene
Ethylene (8ci)
|
Ethylene, compressed
Ethylene, pure
Ethylene-CMPD
Etileno
H2C=ch2
Liquid ethyene
Liquid ethylene
Olefiant gas
Plastipore
Polyethylene as med mol. wt.
R-1150
|
|
Interventional clinical trials:
(show all 49)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Clinical Study of the Treatment of Infertility Caused by Severe Intrauterine Adhesions by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells |
Unknown status |
NCT02204358 |
Phase 4 |
|
2 |
Effectiveness of Self-cross-linked Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion |
Unknown status |
NCT02868437 |
Phase 4 |
|
3 |
New Therapeutic Approaches to Treat Asherman's Syndrome and Endometrial Atrophy Based in BM Stem Cells Autologous Transplantation |
Completed |
NCT02144987 |
Phase 4 |
|
4 |
The Effect of Estrogen in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis |
Enrolling by invitation |
NCT03620929 |
Phase 4 |
Estradiol Valerate |
5 |
Prevalence of Intrauterine Adhesions After the Application of Hyaluronic Acid Gel After Dilatation and Curettage in Women With Spontaneous Abortion or Induction of Abortion From 12+0 Till 23+6 Week of Pregnancy. |
Not yet recruiting |
NCT04671914 |
Phase 4 |
Hyaluronic Acid 20 MG/ML Injectable Solution |
6 |
The Role of Seprafilm Bioresorbable Slurry in the Prevention of Intrauterine Synechiae in Patients Undergoing Hysteroscopic Myomectomy |
Terminated |
NCT01632202 |
Phase 4 |
|
7 |
Non-stick Gel Applicated After Scraping Surgery for Natural Miscarriage and Uterine Synechiae Prevention |
Completed |
NCT02248376 |
Phase 3 |
Gel |
8 |
Platelet-Rich Plasma in the Management of Asherman Syndrome |
Completed |
NCT04308811 |
Phase 2 |
|
9 |
A Prospective, Randomized, Controlled Trial Comparing 2 Different Doses of Estrogen Therapy After Hysteroscopic Adhesiolysis as an Adjuvant to Prevent Recurrence of Intrauterine Adhesions |
Completed |
NCT02726971 |
Phase 1, Phase 2 |
Femoston |
10 |
Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures |
Completed |
NCT03166189 |
Phase 2 |
|
11 |
Fertility Restoration Using Autologous Adipose Tissue Derived Mesenchymal Stem Cells |
Completed |
NCT04432467 |
Phase 1, Phase 2 |
|
12 |
Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy). |
Recruiting |
NCT05095597 |
Phase 2 |
Oestraclin |
13 |
Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair: a Prospective Randomised Pilot Study |
Terminated |
NCT02825849 |
Phase 2 |
|
14 |
Safety and Therapeutic Effect of Human Amniotic Epithelial Cells in Severe Refractory Asherman's Syndrome |
Unknown status |
NCT03223454 |
Phase 1 |
|
15 |
Clinical Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Cells in the Treatment of Moderate and Severe Intrauterine Adhesions |
Unknown status |
NCT04232592 |
Phase 1 |
|
16 |
Cesarean Myomectomy : Safety and Risk of Intrauterine Synechiae |
Completed |
NCT03095014 |
Phase 1 |
|
17 |
Biomedical Study of Toxicity, Biodistribution, Expression and Cellular Characterization of Autologous CD133+ Stem Cells From Donors of Hematopoietic Progenitors (IGX1) in Murine Model With Asherman-induced Syndrome. |
Unknown status |
NCT03665649 |
|
|
18 |
Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery - a Prospective Double Blind Randomized Study |
Unknown status |
NCT01637974 |
|
INTERCOAT administration |
19 |
Treatment of Intrauterine Adhesions and Its Distribution of Genital Tract Flora |
Unknown status |
NCT03731689 |
|
Intrauterine lavage therapy;Intrauterine gel-injection therapy |
20 |
Amnion Graft for Preventing Intrauterine Adhesions Following Hysteroscopic Surgery |
Unknown status |
NCT02132104 |
|
Femoston |
21 |
Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel |
Unknown status |
NCT02404454 |
|
|
22 |
The Efficacy and Safety of the Dried Biological Amnion Graft Following Hysteroscopic Lysis for the Prevention of Postoperative Adhesions in Patients With Intrauterine Adhesions |
Unknown status |
NCT02496052 |
|
estradiol valerate tablets+dydrogesterone Tablets |
23 |
Hysteroscopy Assisted Suction Curettage for Early Pregnancy Loss: Does it Reduce Retained Products of Conception and Postoperative Intrauterine Adhesions? |
Unknown status |
NCT04637373 |
|
|
24 |
Platelet-rich Plasma(PRP) Prevents Recurrence of Intrauterine Adhesions |
Unknown status |
NCT03629132 |
|
|
25 |
Use Of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery |
Unknown status |
NCT01464528 |
Early Phase 1 |
Hyaluronan |
26 |
A Multi-center, Randomized, Single-blind, Controlled Clinical Trial of Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells |
Completed |
NCT02680366 |
|
|
27 |
Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and Quality of Life in Women With Intrauterine Adhesion:a Randomized Controlled Trial. |
Completed |
NCT02746679 |
|
|
28 |
Effects of Intrauterine Platelet Rich Plasma (PRP) on Endometrium and Pregnancy Rates in Patients With Suboptimal Endometrium Undergoing Frozen Embryo Transfer |
Completed |
NCT04424160 |
|
|
29 |
A Randomized Clinical Trial to Assess the Efficacy of Intrauterine Balloon Compared to Intrauterine Contraceptive Device Plus Foley Catheter in the Therapy for Uterine Adhesion After Hysteroscopic Adhesiolysis |
Completed |
NCT02867202 |
|
|
30 |
Intercoat (Oxiplex/AP Gel) for Preventing Intrauterine Adhesions Following Operative Hysteroscopy for Suspected Retained Products of Conception - a Prospective Randomized Pilot Study |
Completed |
NCT01377779 |
|
Oxiplex/AP gel;Normal Saline |
31 |
Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Infertility Due to Severe Intrauterine Adhesions. |
Completed |
NCT02708277 |
|
|
32 |
Prevalence of Chronic Endometritis in Severe Intrauterine Adhesions and Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine |
Completed |
NCT02744807 |
|
|
33 |
Clinical Study of the Treatment of Infertility Caused by Recurrent Intrauterine Adhesions by Collagen Scaffold Loaded With Umbilical Cord -Derived Mesenchymal Stem Cells (UC-MSCs) |
Completed |
NCT02313415 |
|
|
34 |
Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions (IUA) 3, 6 and 12 Months Following Endometrial Ablation: A Prospective Single-Center Observational Study |
Completed |
NCT04824430 |
|
|
35 |
The Value of Using Platelet Rich Plasma After Hysteroscopic Lysis of Severe Intrauterine Adhesions (A Randomized Controlled Trial) |
Completed |
NCT03541746 |
|
|
36 |
Autocrosslinked Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Bipolar Radiofrequency Endometrial Ablation: a Randomised, Controlled and Double Blind Study |
Completed |
NCT01829451 |
|
|
37 |
A Placebo Comparative, Evaluator Blinded, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy |
Completed |
NCT04638855 |
|
|
38 |
Endometrial Reconstruction by Human Regenerative Factors Derived From Platelet-Rich Plasma in Mice Models |
Recruiting |
NCT03249415 |
|
|
39 |
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film. |
Recruiting |
NCT04963179 |
|
|
40 |
The Cost-effectiveness of Anti-adhesion Treatment With HYALOBARRIER® GEL ENDO Versus no Gel Following the Removal by Hysteroscopy of Endometrial Polyps, Fibroids With Uterine Cavity Deformation, Uterine Septa, Intrauterine Adhesions or Retained Products of Conception for Improving Reproductive Outcome in Women Wishing to Become Pregnant: a Multi-centre, Parallel Group, Superiority, Double-blind, Randomized Controlled Trial |
Recruiting |
NCT03880435 |
|
|
41 |
Intrauterine Adhesions Prevention: the Use of Heparin Solution Compared to Application of Anti-adhesion Barrier Gel After Operative Hysteroscopy |
Recruiting |
NCT05257213 |
|
Heparin solution;Anti-adhesion barrier gel |
42 |
The Value of Three-dimensional Ultrasound Applying in Pre and Postoperative Assessment and Prognosis of Intrauterine Adhesions |
Recruiting |
NCT04930913 |
|
|
43 |
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions |
Recruiting |
NCT05003869 |
|
|
44 |
Reduction of Intrauterine Adhesions by Intrauterine Hyaluronic Acid Gel After Hysteroscopic Removal of Retained Products of Conception: Multicenter Prospective Randomized Trial |
Active, not recruiting |
NCT04975373 |
|
Intrauterine injection of hyaluronic acid |
45 |
Establishment and Application of Endometrial 3D-organoid in Endometrial Injury Repair |
Not yet recruiting |
NCT05521932 |
|
|
46 |
Bone Marrow Derived Stem Cells Mobilization for Treatment of Asherman's Syndrome, Atrophic Endometrium, and Recurrent Implantation Failure |
Not yet recruiting |
NCT05343572 |
Early Phase 1 |
Plerixafor |
47 |
Evaluation of Adhesions Formation Using Conventional Third Generation Endometrial Ablation With and Without Postoperative Application of an Intrauterine Adhesion Barrier Film |
Not yet recruiting |
NCT05414760 |
|
|
48 |
Prevalence of Intrauterine Adhesions After Abdominal Myomectomy |
Not yet recruiting |
NCT04030273 |
|
|
49 |
MONOBISY: Randomized Controlled Trial Comparing Intra Uterine Synechiae Occurence Using Bipolar Energy Compared With Monopolar Energy in Myoma Resection on Women Having Menorraghia and/or Infertility |
Withdrawn |
NCT02661087 |
|
|
|